rs587779527
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000090.4(COL3A1):c.1786C>T(p.Arg596Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000090.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL3A1 | NM_000090.4 | c.1786C>T | p.Arg596Ter | stop_gained | 25/51 | ENST00000304636.9 | NP_000081.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL3A1 | ENST00000304636.9 | c.1786C>T | p.Arg596Ter | stop_gained | 25/51 | 1 | NM_000090.4 | ENSP00000304408 | P1 | |
COL3A1 | ENST00000450867.2 | c.1687C>T | p.Arg563Ter | stop_gained | 24/50 | 1 | ENSP00000415346 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461838Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727222
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 05, 2019 | - - |
Pathogenic, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | Jul 08, 2019 | This variant is interpreted as a Pathogenic for Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome, autosomal recessive. The following ACMG Tag(s) were applied: PM2, PVS1, PP1. - |
Ehlers-Danlos syndrome, type 4 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 24, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 242648). This premature translational stop signal has been observed in individual(s) with Ehlers-Danlos syndrome, vascular type (PMID: 25205403, 25758994). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg596*) in the COL3A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL3A1 are known to be pathogenic (PMID: 24922459). - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 20, 2022 | Identified in compound heterozygous state with a missense COL3A1 variant in two siblings with vEDS; however, family members who were only heterozygous for p.(R596*) had no major features of vEDS, indicating marked clinical variability (Pepin et al., 2014; Jorgensen et al., 2015); Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25205403, 28258187, 30474650, 24922459, 25758994) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at